QUIDELORTHO CORPORATION Financials QuidelOrtho Corporation
Equities
QDEL
US2197981051
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.64 USD | -0.13% |
|
+1.33% | -46.21% |
| Apr. 02 | QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay | MT |
| Apr. 02 | QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 3,125 | 7,557 | 5,626 | 5,658 | 4,925 | 2,651 | - | - |
| Enterprise Value (EV) 1 | 3,085 | 7,068 | 4,797 | 7,951 | 7,172 | 4,713 | 4,394 | 3,839 |
| P/E ratio | 43.4 x | 9.66 x | 8.22 x | 8.96 x | -491 x | -35.1 x | 40.9 x | -38.9 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 5.84 x | 4.55 x | 3.31 x | 1.73 x | 1.64 x | 0.95 x | 0.91 x | 0.85 x |
| EV / Revenue | 5.77 x | 4.25 x | 2.82 x | 2.43 x | 2.39 x | 1.69 x | 1.51 x | 1.23 x |
| EV / EBITDA | 19.8 x | 6.37 x | 4.82 x | 5.97 x | 9.92 x | 7.91 x | 6.31 x | 5.48 x |
| EV / FCF | 28.8 x | 12.5 x | 9.35 x | 10.7 x | 26.6 x | 22.3 x | 11.5 x | 8 x |
| FCF Yield | 3.48% | 7.99% | 10.7% | 9.36% | 3.76% | 4.48% | 8.66% | 12.5% |
| Price to Book | 5.61 x | 5.7 x | 2.92 x | 1.15 x | 0.98 x | 0.54 x | 0.53 x | - |
| Nbr of stocks (in thousands) | 41,652 | 42,068 | 41,675 | 66,045 | 66,819 | 66,879 | - | - |
| Reference price 2 | 75.03 | 179.6 | 135.0 | 85.67 | 73.70 | 39.64 | 39.64 | 39.64 |
| Announcement Date | 2/12/20 | 2/18/21 | 2/17/22 | 2/15/23 | 2/13/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 534.9 | 1,662 | 1,699 | 3,266 | 2,998 | 2,794 | 2,908 | 3,125 |
| EBITDA 1 | 156.2 | 1,109 | 995.6 | 1,331 | 723.2 | 595.4 | 696.3 | 700.2 |
| EBIT 1 | 92.72 | 1,060 | 906.1 | 843.7 | 139.1 | 304.4 | 418.2 | 469 |
| Operating Margin | 17.33% | 63.81% | 53.34% | 25.83% | 4.64% | 10.89% | 14.38% | 15.01% |
| Earnings before Tax (EBT) 1 | 77.18 | 1,040 | 900.4 | 735.9 | -29.1 | -116.8 | 31.52 | -89.5 |
| Net income 1 | 72.92 | 810.3 | 704.2 | 548.7 | -10.1 | -65.05 | 85.21 | -68.5 |
| Net margin | 13.63% | 48.76% | 41.46% | 16.8% | -0.34% | -2.33% | 2.93% | -2.19% |
| EPS 2 | 1.730 | 18.60 | 16.43 | 9.560 | -0.1500 | -1.130 | 0.9700 | -1.020 |
| Free Cash Flow 1 | 107.3 | 564.8 | 513.1 | 744.4 | 269.6 | 211 | 380.5 | 480 |
| FCF margin | 20.05% | 33.99% | 30.21% | 22.79% | 8.99% | 7.55% | 13.09% | 15.36% |
| FCF Conversion (EBITDA) | 68.68% | 50.91% | 51.54% | 55.93% | 37.28% | 35.44% | 54.65% | 68.55% |
| FCF Conversion (Net income) | 147.09% | 69.71% | 72.87% | 135.67% | - | - | 446.55% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 2/12/20 | 2/18/21 | 2/17/22 | 2/15/23 | 2/13/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 509.7 | 636.9 | 1,002 | 613.4 | 783.8 | 866.5 | 846.1 | 665.1 | 744 | 742.6 | 698.2 | 644.5 | 680.2 | 771 | 704.5 |
| EBITDA 1 | 294.6 | 405.8 | 647.9 | 218.2 | 226.8 | 245.1 | 245.3 | 113.3 | 169.2 | 195.4 | 148.6 | 98.12 | 136.2 | 209.3 | 176 |
| EBIT 1 | 281.8 | 376.7 | 620.7 | 79.7 | 56.8 | 86.5 | 131.1 | 60.1 | 26.3 | 40.1 | 76.31 | 24.76 | 65.07 | 138.5 | 89.62 |
| Operating Margin | 55.29% | 59.15% | 61.93% | 12.99% | 7.25% | 9.98% | 15.49% | 9.04% | 3.53% | 5.4% | 10.93% | 3.84% | 9.57% | 17.96% | 12.72% |
| Earnings before Tax (EBT) 1 | 281.5 | 375.4 | 620.6 | 42.9 | 31.3 | 41.1 | 60 | -64.4 | -15.5 | -9.2 | -35.32 | -96.99 | -42.93 | 38.51 | 8.878 |
| Net income 1 | 215.8 | 291.3 | 479.9 | 19.3 | 19.2 | 30.3 | 48.8 | -53.2 | -12.7 | 7 | -27.11 | -73.49 | -32.2 | 29.26 | 6.408 |
| Net margin | 42.33% | 45.74% | 47.89% | 3.15% | 2.45% | 3.5% | 5.77% | -8% | -1.71% | 0.94% | -3.88% | -11.4% | -4.73% | 3.79% | 0.91% |
| EPS 2 | 5.080 | 6.850 | 11.31 | 0.3600 | 0.2800 | 0.4500 | 0.7300 | -0.8000 | -0.1900 | 0.1000 | -0.4533 | -1.023 | -0.4733 | 0.4300 | 0.0950 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/4/21 | 2/17/22 | 5/4/22 | 8/4/22 | 11/2/22 | 2/15/23 | 5/3/23 | 8/8/23 | 11/1/23 | 2/13/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 2,293 | 2,247 | 2,062 | 1,743 | 1,188 |
| Net Cash position 1 | 40.1 | 490 | 829 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | 1.723 x | 3.107 x | 3.462 x | 2.503 x | 1.697 x |
| Free Cash Flow 1 | 107 | 565 | 513 | 744 | 270 | 211 | 381 | 480 |
| ROE (net income / shareholders' equity) | 25.9% | 91.8% | 46.6% | 24.9% | 5.59% | 3.31% | 4.77% | 4.59% |
| ROA (Net income/ Total Assets) | 14.9% | 62.4% | 35.3% | 15.2% | 3.19% | 2.1% | 3.4% | - |
| Assets 1 | 489.8 | 1,298 | 1,994 | 3,619 | -316.8 | -3,098 | 2,506 | - |
| Book Value Per Share 2 | 13.40 | 31.50 | 46.20 | 74.30 | 75.10 | 73.70 | 75.20 | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 27.2 | 64.9 | 293 | 141 | 191 | 182 | 191 | 32 |
| Capex / Sales | 5.09% | 3.91% | 17.23% | 4.31% | 6.38% | 6.51% | 6.55% | 1.02% |
| Announcement Date | 2/12/20 | 2/18/21 | 2/17/22 | 2/15/23 | 2/13/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
39.64
USD
Average target price
54.73
USD
Spread / Average Target
+38.08%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -46.21% | 2.65B | |
| -12.91% | 19.08B | |
| +18.15% | 1.87B | |
| -3.12% | 1.61B | |
| +23.78% | 1.21B | |
| -10.69% | 1.02B | |
| -20.89% | 905M | |
| -7.14% | 716M | |
| -18.10% | 682M | |
| +4.01% | 480M |
- Stock Market
- Equities
- QDEL Stock
- Financials QuidelOrtho Corporation
